HealthTech company Climedo has received EUR5 million in a seed financing round led by pan-European VC firm Nauta Capital. Westtech Ventures from Berlin and existing business angels including as Prof Dr Christian Wallwiener (WMC Healthcare) also participated in the round.  Climedo is a digital platform for electronic data capture in decentralized clinical trials. The company will use the new capital for expanding within Europe and for further developing its software solutions.  For VC Nauta Capital, this is the fourth investment in the digital health sector.

Qumata, a specialist in tech solutions transforming the insurance industry ecosystem with a disruptive machine learning and artificial intelligence (ML/AI) underwriting solution, has extended its Series A round of funding to USD23 million. A number of the firms participating in this round are extending their initial involvement with Qumata, including continued investment by MMC Ventures. This extended funding announcement comes on the back of the firms signing an agreement recently with AIA Group Limited (1299.HK) to provide services across Asia. Qumata’s solutions support the acceleration of the digital transformation of the life and health insurance industry, with Asia being at

SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, has closed an oversubscribed EUR50 million series A financing co-led by UCB Ventures and existing shareholder Ysios Capital. New investors New Enterprise Associates (NEA), Gilde Healthcare, Novartis Venture Fund, and existing shareholder Asabys Partners also particpated.  The Company was seeded in 2020 by Ysios Capital and Asabys Partners. The proceeds from the financing, the largest Series A round for a Spanish biotech company, will enable SpliceBio to build a pipeline of Protein Splicing gene therapy programmes, while advancing the lead program in Stargardt disease to the clinic. 

TruArc Partners, a private equity firm focused on the middle-market, has invested in New Directions Aromatics (New Directions) in partnership with Founder and CEO, Alex Thomas. Based in Toronto, New Directions is a supplier of natural ingredients to the cosmetics, health and beauty and personal care markets.    The newly formed partnership will provide New Directions with significant resources and capital to take advantage of growing demand for natural and organic products. Together, TruArc and New Directions will drive growth by supporting the development of value-add capabilities, people, and technology, as well as pursuing add-on acquisitions.   Terms of the

The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in PaleoWest, a Phoenix-based cultural resource management consulting firm. Founded in 2006, PaleoWest is a professional consultancy that assists clients with their need to address federal, state and local level environmental regulations, typically in support of a wide variety of land development projects such as the permitting solar and wind generation facilities, housing developments, roads and bridges and other major infrastructure development projects. PaleoWest’s practice focuses on archaeology, historic architecture, paleontology and other related environmental services.

Scrona AG, an additive manufacturing startup, has closed a USD9.6 million Series A financing led led by AM Ventures with syndicate partners including TRUMPF Venture, Verve Ventures and Manz GmbH Management Consulting and Investment.

SourceDay, a supply chain procurement collaboration engine for direct spend materials and one of Austin’s fastest-growing companies, has closed a USD31.5 million Series C round of funding. The round was led by Norwest Venture Partners with participation from existing investors ATX Ventures, Baird Capital, Draper Associates, Ring Ventures and Silverton Partners. SourceDay will use its Series C funds to accelerate its recruiting efforts, reinforce the company’s sales, channel and marketing engines, and maintain its continued investment in operations and customer success from 2021. The company plans to double its product and engineering teams and bring on a product leader to

SIMON Markets (SIMON), a fintech company that offers an end-to-end digital suite of tools to help financial professionals understand, manage, and analyse complex alternative investment products, has secured a strategic investment from Citi. Citi is a longtime partner of SIMON, both as a leading issuer of structured investments and through its wealth management division whose financial professionals use the investment platform. 

Passthrough, a data-driven subscription document platform that seamlessly automates, distributes, executes, and manages the subscription process for fund managers and their investors, has raised USD5 million. Positive Sum led the round with participation from Okta Ventures, Great Oaks VC, and Company Ventures. Additional strategic angel investors and operators also participated in the round including Samir Kaji (Founder and CEO of Allocate); Bob Moore (CEO of Crossbeam); Josh Smith (co-founder and former CEO of Solovis, a leading institutional investment portfolio management system); Marshall Boyd (Co-President/Chief Investment Officer at Interstate Equities Corp.); Andrea Walne (General Partner at Manhattan Venture Partners); Daniel McAuley